MedTrace Logo

Clinical Study of the Medeon Biodesign XPro™

NCT03171155 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2019-09-20

No results posted yet for this study

Summary

To access the safety and performance of the XPro System to facilitate hemostasis in patients undergoing percutaneous endovascular procedures utilizing 8-18 Fr introducer sheath via the common femoral.

Conditions

  • Percutaneous Closure of Arteriotomy in Common Femoral Artery

Interventions

DEVICE

XPro System

Implantation of the XPro System

Sponsors & Collaborators

  • Medeon Biodesign, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-25
Primary Completion
2019-07-25
Completion
2019-09-12

Countries

  • Australia
  • New Zealand
  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03171155 on ClinicalTrials.gov